181 related articles for article (PubMed ID: 36139430)
1. MYH9 Facilitates Cell Invasion and Radioresistance in Head and Neck Cancer via Modulation of Cellular ROS Levels by Activating the MAPK-Nrf2-GCLC Pathway.
You GR; Chang JT; Li YL; Huang CW; Tsai YL; Fan KH; Kang CJ; Huang SF; Chang PH; Cheng AJ
Cells; 2022 Sep; 11(18):. PubMed ID: 36139430
[TBL] [Abstract][Full Text] [Related]
2. MiR-630 Promotes Radioresistance by Induction of Anti-Apoptotic Effect via Nrf2-GPX2 Molecular Axis in Head-Neck Cancer.
You GR; Cheng AJ; Shen EY; Fan KH; Huang YF; Huang YC; Chang KP; Chang JT
Cells; 2023 Dec; 12(24):. PubMed ID: 38132173
[TBL] [Abstract][Full Text] [Related]
3. Molecular Interplays Between Cell Invasion and Radioresistance That Lead to Poor Prognosis in Head-Neck Cancer.
You GR; Chang JT; Li YL; Chen YJ; Huang YC; Fan KH; Chen YC; Kang CJ; Cheng AJ
Front Oncol; 2021; 11():681717. PubMed ID: 34307149
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
5. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells.
Song NY; Kim DH; Kim EH; Na HK; Kim NJ; Suh YG; Surh YJ
Chem Res Toxicol; 2011 Aug; 24(8):1231-41. PubMed ID: 21728338
[TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibition induces a p38 MAPK pathway-dependent antiapoptotic program via Nrf2 in thyroid cancer cells.
Du ZX; Yan Y; Zhang HY; Liu BQ; Gao YY; Niu XF; Meng X; Wang HQ
J Clin Endocrinol Metab; 2011 May; 96(5):E763-71. PubMed ID: 21346076
[TBL] [Abstract][Full Text] [Related]
8. GDF15 contributes to radioresistance and cancer stemness of head and neck cancer by regulating cellular reactive oxygen species via a SMAD-associated signaling pathway.
Li YL; Chang JT; Lee LY; Fan KH; Lu YC; Li YC; Chiang CH; You GR; Chen HY; Cheng AJ
Oncotarget; 2017 Jan; 8(1):1508-1528. PubMed ID: 27903972
[TBL] [Abstract][Full Text] [Related]
9. Chalcone flavokawain A attenuates TGF-β1-induced fibrotic pathology via inhibition of ROS/Smad3 signaling pathways and induction of Nrf2/ARE-mediated antioxidant genes in vascular smooth muscle cells.
Hseu YC; Yang TY; Li ML; Rajendran P; Mathew DC; Tsai CH; Lin RW; Lee CC; Yang HL
J Cell Mol Med; 2019 Feb; 23(2):775-788. PubMed ID: 30549180
[TBL] [Abstract][Full Text] [Related]
10. Vanadate oxidative and apoptotic effects are mediated by the MAPK-Nrf2 pathway in layer oviduct magnum epithelial cells.
Wang J; Huang X; Zhang K; Mao X; Ding X; Zeng Q; Bai S; Xuan Y; Peng H
Metallomics; 2017 Nov; 9(11):1562-1575. PubMed ID: 29022012
[TBL] [Abstract][Full Text] [Related]
11. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
Shin D; Kim EH; Lee J; Roh JL
Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic role of baicalein in combating experimental periodontitis with diabetes via Nrf2 antioxidant signaling pathway.
Zhu C; Zhao Y; Wu X; Qiang C; Liu J; Shi J; Gou J; Pei D; Li A
J Periodontal Res; 2020 Jun; 55(3):381-391. PubMed ID: 31854466
[TBL] [Abstract][Full Text] [Related]
13. Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer.
Kim EH; Jang H; Shin D; Baek SH; Roh JL
Apoptosis; 2016 Nov; 21(11):1265-1278. PubMed ID: 27544755
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy.
Zhong Q; Mishra M; Kowluru RA
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):3941-8. PubMed ID: 23633659
[TBL] [Abstract][Full Text] [Related]
15. PM2.5 induces Nrf2-mediated defense mechanisms against oxidative stress by activating PIK3/AKT signaling pathway in human lung alveolar epithelial A549 cells.
Deng X; Rui W; Zhang F; Ding W
Cell Biol Toxicol; 2013 Jun; 29(3):143-57. PubMed ID: 23525690
[TBL] [Abstract][Full Text] [Related]
16. Curcumin attenuates oxidative stress in RAW264.7 cells by increasing the activity of antioxidant enzymes and activating the Nrf2-Keap1 pathway.
Lin X; Bai D; Wei Z; Zhang Y; Huang Y; Deng H; Huang X
PLoS One; 2019; 14(5):e0216711. PubMed ID: 31112588
[TBL] [Abstract][Full Text] [Related]
17. Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia.
Ungvari Z; Bailey-Downs L; Gautam T; Jimenez R; Losonczy G; Zhang C; Ballabh P; Recchia FA; Wilkerson DC; Sonntag WE; Pearson K; de Cabo R; Csiszar A
Am J Physiol Heart Circ Physiol; 2011 Apr; 300(4):H1133-40. PubMed ID: 21217061
[TBL] [Abstract][Full Text] [Related]
18. Activation of the MAPK/Akt/Nrf2-Egr1/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ2-mediated cell death.
Koyani CN; Kitz K; Rossmann C; Bernhart E; Huber E; Trummer C; Windischhofer W; Sattler W; Malle E
Biochem Pharmacol; 2016 Mar; 104():29-41. PubMed ID: 26801686
[TBL] [Abstract][Full Text] [Related]
19. Targeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer.
Roh JL; Jang H; Kim EH; Shin D
Antioxid Redox Signal; 2017 Jul; 27(2):106-114. PubMed ID: 27733046
[TBL] [Abstract][Full Text] [Related]
20. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
Tang YC; Hsiao JR; Jiang SS; Chang JY; Chu PY; Liu KJ; Fang HL; Lin LM; Chen HH; Huang YW; Chen YT; Tsai FY; Lin SF; Chuang YJ; Kuo CC
Theranostics; 2021; 11(11):5232-5247. PubMed ID: 33859744
[No Abstract] [Full Text] [Related]
[Next] [New Search]
